Mycoplasma genitalium screening in a specialized French unit: A retrospective study

Autor: Herms, F., Poizeau, F., Anyfantakis, V., Bonhomme, P., Chaine-Sidibé, B., Louison, J.-B., Berçot, B., Bagot, M., Fouéré, S.

Publikováno v: In Annales de Dermatologie et de Vénéréologie September 2022 149(3):165-168

Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 × 2 factorial design.

Autor: Molina JM; Department of Infectious Diseases, Hospital Saint-Louis, Hospital Lariboisière, INSERM U944, Assistance Publique Hôpitaux de Paris, University of Paris Cité, Paris, France. Electronic address: jean-michel.molina@aphp.fr., Bercot B; Laboratory of Microbiology, Hospital Saint-Louis, Hospital Lariboisière, INSERM U944, Assistance Publique Hôpitaux de Paris, University of Paris Cité, Paris, France; Department of Bacteriology, UMR CNRS 5234, French National Center for Bacterial Sexually Transmitted Infections, Bordeaux, France., Assoumou L; Sorbonne University, INSERM, Institut Pierre Louis d'Epidemiology et de Santé Publique, Paris, France., Rubenstein E; Department of Infectious Diseases, Hospital Saint-Louis, Hospital Lariboisière, INSERM U944, Assistance Publique Hôpitaux de Paris, University of Paris Cité, Paris, France., Algarte-Genin M; Sorbonne University, INSERM, Institut Pierre Louis d'Epidemiology et de Santé Publique, Paris, France., Pialoux G; Department of Infectious Diseases, Hôpital Tenon, Paris, France., Katlama C; Sorbonne University, INSERM, Institut Pierre Louis d'Epidemiology et de Santé Publique, Paris, France; Department of Infectious Diseases, Hospital of la Pitié-Salpétrière, Paris, France., Surgers L; Sorbonne University, INSERM, Institut Pierre Louis d'Epidemiology et de Santé Publique, Paris, France; Department of Infectious Diseases, Hospital Saint-Antoine, Sorbonne Université, Paris, France., Bébéar C; Department of Bacteriology, UMR CNRS 5234, French National Center for Bacterial Sexually Transmitted Infections, Bordeaux, France., Dupin N; Department of Dermatology, Hospital Cochin, Paris, France., Ouattara M; Sorbonne University, INSERM, Institut Pierre Louis d'Epidemiology et de Santé Publique, Paris, France., Slama L; Department of Immunology and Infectious Diseases, Hotel-Dieu, Paris, France., Pavie J; Department of Clinical Immunology, Hotel-Dieu, Paris, France., Duvivier C; Department of Infectious Diseases, INSERM U1016, Necker Pasteur Infectiology Center, Hospital Bichat, University of Paris Cité, Paris, France., Loze B; Department of Infectious Diseases, Hospital Saint-Louis, Hospital Lariboisière, INSERM U944, Assistance Publique Hôpitaux de Paris, University of Paris Cité, Paris, France., Goldwirt L; Department of Pharmacology, Hospital Saint-Louis, Hospital Lariboisière, INSERM U944, Assistance Publique Hôpitaux de Paris, University of Paris Cité, Paris, France., Gibowski S; ANRS Maladies Infectieuses Emergentes, Paris, France., Ollivier M; ANRS Maladies Infectieuses Emergentes, Paris, France., Ghosn J; Department of Infectious Diseases, IAME UMR1137, Hospital Bichat, University of Paris Cité, Paris, France., Costagliola D; Sorbonne University, INSERM, Institut Pierre Louis d'Epidemiology et de Santé Publique, Paris, France.

Publikováno v: The Lancet. Infectious diseases [Lancet Infect Dis] 2024 Oct; Vol. 24 (10), pp. 1093-1104. Date of Electronic Publication: 2024 May 23.

New Insights Into the Therapeutic Management of Varicella Zoster Virus Meningitis: A Series of 123 Polymerase Chain Reaction-Confirmed Cases.

Autor: Dulin M; Department of Infectious Diseases, Saint Louis-Lariboisière Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France., Chevret S; Biostatistics Department, Saint Louis Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France., Salmona M; Laboratory of Virology, Saint Louis-Lariboisière-Fernand-Widal Hospital Group, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France., Jacquier H; Laboratory of Microbiology, Saint Louis-Lariboisière-Fernand-Widal Hospital Group, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France., Bercot B; Laboratory of Microbiology, Saint Louis-Lariboisière-Fernand-Widal Hospital Group, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France., Molina JM; Department of Infectious Diseases, Saint Louis-Lariboisière Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France., Lebeaux D; Department of Infectious Diseases, Saint Louis-Lariboisière Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France., Munier AL; Department of Infectious Diseases, Saint Louis-Lariboisière Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France.

Publikováno v: Open forum infectious diseases [Open Forum Infect Dis] 2024 Jun 20; Vol. 11 (7), pp. ofae340. Date of Electronic Publication: 2024 Jun 20 (Print Publication: 2024).

Antimicrobial-resistant Neisseria gonorrhoeae in Europe in 2020 compared with in 2013 and 2018: a retrospective genomic surveillance study.

Autor: Golparian D; WHO Collaborating Centre for Gonorrhoea and Other Sexually Transmitted Infections, Department of Laboratory Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden., Cole MJ; UK Health Security Agency, London, UK., Sánchez-Busó L; Genomics and Health Area, Foundation for the Promotion of Health and Biomedical Research in the Valencian Community (FISABIO-Public Health), Valencia, Spain; CIBERESP, ISCIII, Madrid, Spain., Day M; UK Health Security Agency, London, UK., Jacobsson S; WHO Collaborating Centre for Gonorrhoea and Other Sexually Transmitted Infections, Department of Laboratory Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden., Uthayakumaran T; UK Health Security Agency, London, UK., Abad R; Reference Laboratory for Neisseria, National Centre of Microbiology-Instituto de Salud Carlos III, Majadahonda, Spain., Bercot B; French National Reference Center for Bacterial STI, Associated Laboratory for Gonococci, APHP, Paris Cité University, IAME 1137, Paris, France., Caugant DA; Norwegian Institute of Public Health, Oslo, Norway., Heuer D; Unit 18: 'Sexually Transmitted Bacterial Pathogens and HIV', Department of Infectious Disease, Robert Koch Institute, Berlin, Germany., Jansen K; Unit 34: 'HIV/AIDS, STI and Blood-Borne Infections', Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany., Pleininger S; Austrian Agency for Health and Food Safety, Vienna, Austria., Stefanelli P; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy., Aanensen DM; Centre for Genomic Pathogen Surveillance, Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Bluemel B; European Centre for Disease Prevention and Control, Stockholm, Sweden., Unemo M; WHO Collaborating Centre for Gonorrhoea and Other Sexually Transmitted Infections, Department of Laboratory Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden; Institute for Global Health, University College London, London, UK. Electronic address: magnus.unemo@regionorebrolan.se.

Publikováno v: The Lancet. Microbe [Lancet Microbe] 2024 May; Vol. 5 (5), pp. e478-e488. Date of Electronic Publication: 2024 Apr 10.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.